Results 61 to 70 of about 48,590 (264)
Movement Disorders Clinical Practice, EarlyView.Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz +2 more
wiley +1 more source
Orofacial Drinking Tremor: A Case Series and Literature Review
Movement Disorders Clinical Practice, EarlyView.Abstract Background Task‐specific orofacial tremor is a rare condition in which rhythmic oscillations of orofacial muscles occur during specific actions. Drinking tremor represents a recurrent pattern in isolated reports, although its phenomenology and underlying mechanisms remain incompletely defined.
Daniele Birreci +7 more
wiley +1 more source
RÜLFS CRAMP AND OTHER PAROXYSMAL DYSKINESIA
Эпилепсия и пароксизмальные состояния, 2016 Paroxysmal dyskinesia comprise a significant and fascinating part of movement disorders, which represent a diagnostic challenge for neurologists working on the borderlands of psychiatry and epilepsy.
M. V. Selikhova +4 more
doaj
Esthetics in ophthalmology: Noninvasive options of facial rejuvenation
TNOA Journal of Ophthalmic Science and Research, 2018 Facial aging is an ongoing biological process governed by both intrinsic and extrinsic factors. Conventionally, surgical treatments remained superior for decades due to satisfactory outcome.
Atanu Barh, Bipasha Mukherjee
doaj +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Hyperkinetic movement disorders, including dystonia, tremor, and myoclonus, are disabling conditions often managed with botulinum toxin type A (BoNT‐A). Real‐world evidence on treatment patterns remains limited. Objective This nationwide, population‐based study aimed to evaluate trends in BoNT‐A use in France between 2015 and 2023 ...
Marion Simonetta‐Moreau +3 more
wiley +1 more source
TREATMENT OF PARADOXICAL VOCAL FOLD MOTION IN A 12-YEAR-OLD PATIENT WITH PATAU’S SYNDROME
Euromediterranean Biomedical Journal, 2019 We describe the case of a 12-year-old girl with paradoxical vocal fold motion (PVFM) secondary to partial Patau’s syndrome, successfully treated with botulinum toxin A (BTX-A) injection to the vocal folds.
Viviana Nicastro
doaj +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Functional movement disorder (FMD), a subtype of functional neurological disorder, is a complex neuropsychiatric syndrome characterized by inconsistent and incongruent motor symptoms. Despite its relatively high prevalence, FMD remains associated with delayed diagnosis, significant disability, and limited evidence to guide ...
Andrea Soumbasis +6 more
wiley +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Task‐specific tremors (TST) and position‐dependent tremors (PDT) are rare isolated focal tremors that impair fine motor control with few effective treatment options. Although botulinum neurotoxin (BoNT) is effective in other tremor syndromes, its evidence in these tremor subtypes remains limited.
Elizabeth K. Boyd +3 more
wiley +1 more source
Pseudo‐Dystonic Gait in a Preschool Child: Foot Posturing Contralateral to a Cuboid Fracture
Movement Disorders Clinical Practice, EarlyView.
Allison J. Chirigos +4 more
wiley +1 more source
Distinct Brain Drivers and Shared Cerebello–Cortical Input in ADCY5 and SGCE Hyperkinetic Movements
Movement Disorders, EarlyView.Resting‐state fMRI and effective connectivity revealed distinct cerebellar–basal ganglia–cortical interactions in ADCY5 (MxMD‐ADCY5) and SGCE (MYC/DYT‐SGCE) related movement disorders. The cerebellum modulated cortex directly in MYC/DYT‐SGCE, but indirectly via basal ganglia‐cerebellar projections in MxMD‐ADCY5, which also showed reduced subthalamic ...
Clément Tarrano +33 more
wiley +1 more source